Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : John, Mike & Tom's Wild World of Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Jorj X Mckie who wrote (365)	2/25/2000 11:37:00 AM
From: wlheatmoon	Respond to of 2850

from TA perspective,,,it must look great...from FA perspective,,,the oral heparin doesn't make me want to jump in...it's not a big deal as far as i can tell..heparin is a blood thinner....there are already oral blood thinners out there.... just noticed they have oral calcitonin...that may be a big thing to help osteoporosis,,,but it's a ways from being a real product. in these biotechs,,,with products coming in the future,,,i think the TA is even more valuable than the FA if FA is reasonable... They also plan on selling 2.5 million shares for 129.5 million...so there's good support level from current price. mike